Dr. James N. Brenton, MD

Dr. Brenton practices at University of Virginia Physicians Group in Charlottesville, Virginia.

Dr. Brenton's NPI, 1811156284, was assigned on June 2, 2008. Dr. Brenton graduated from Indiana University School of Medicine in 2008. Dr. Brenton holds Virginia license 0101256307.

Dr. Brenton's primary practice is University of Virginia Physicians Group, at 1221 Lee St, Charlottesville, VA 22903 in Charlottesville City. The practice phone is (434) 295-1000.

Dr. Brenton's primary practice is University of Virginia Physicians Group in Charlottesville, Virginia. Dr. Brenton is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Brenton to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brenton practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Brenton's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Brenton is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Brenton's licenses on file in 2 states: Virginia and Ohio.

Dmand AI lists multiple sclerosis among the conditions Dr. Brenton treats.

CMS data shows 42 Medicare services from Dr. Brenton across 2 procedure codes in 2024, for 31 Medicare patients. Medicare paid $5,453 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Dr. Brenton in 2024. The largest group is 75 to 84, with 14 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brenton's median patient age at 18, with 55% women.

In 2024, Dr. Brenton wrote 37 Medicare Part D claims. 95% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $195 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Brenton for performance year 2024, reported as part of a group. Dr. Brenton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 68 papers to Dr. Brenton, published from 2012 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Multiple Sclerosis, Status Epilepticus and Anticonvulsants. Dr. Brenton has published most often in Pediatr Neurol. Dr. Brenton's most frequent co-authors are Tobias Loddenkemper, MD, Mohamad Abdul Ghani Mikati, MD and Kevin E. Chapman, MD.

Dmand AI links Dr. Brenton to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Nerve Degeneration. University of Virginia sponsors the most, 2.

CMS Open Payments shows 13 general payments to Dr. Brenton from 4 drug and device companies from 2016 to 2022. Travel and lodging make up the largest share, 62% of the total. Novartis Pharma AG paid the most, $10,572.

Dr. Brenton graduated from Indiana University School of Medicine in 2008. Dr. Brenton is a member of AAN, American Neurologic Association, Child Neurology Society and International Paediatric Multiple Sclerosis Study Group.

Dr. Brenton is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.